BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15264381)

  • 1. Survey of colorectal cancer screening practices in a large Canadian urban centre.
    Mack LA; Stuart H; Temple WJ
    Can J Surg; 2004 Jun; 47(3):189-94. PubMed ID: 15264381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007.
    Klabunde CN; Lanier D; Nadel MR; McLeod C; Yuan G; Vernon SW
    Am J Prev Med; 2009 Jul; 37(1):8-16. PubMed ID: 19442479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening: practices and attitudes of gastroenterologists, internists and surgeons.
    Hilsden RJ; McGregor E; Murray A; Khoja S; Bryant H
    Can J Surg; 2005 Dec; 48(6):434-40. PubMed ID: 16417049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns.
    Schroy PC; Barrison AF; Ling BS; Wilson S; Geller AC
    Am J Gastroenterol; 2002 Apr; 97(4):1031-6. PubMed ID: 12008667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Care Provider Characteristics Associated With Colorectal Cancer Screening Preferences and Use.
    Finney Rutten LJ; Parks PD; Weiser E; Fan C; Jacobson DJ; Jenkins GD; Zhu X; Griffin JM; Limburg PJ
    Mayo Clin Proc; 2022 Jan; 97(1):101-109. PubMed ID: 34920895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopist Specialty Predicts the Likelihood of Recommending Cessation of Colorectal Cancer Screening in Older Adults.
    Calderwood AH; Anderson JC; Robinson CM; Butterly LF
    Am J Gastroenterol; 2018 Dec; 113(12):1862-1871. PubMed ID: 30390031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician barriers to population-based, fecal occult blood test-based colorectal cancer screening programs for average-risk patients.
    McGregor S; Hilsden R; Yang H
    Can J Gastroenterol; 2010 Jun; 24(6):359-64. PubMed ID: 20559577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer screening in hospitalized patients: results from the Nationwide Inpatient Sample.
    Eke R; Tariq T; Li T; Irfan FB
    Eur J Cancer Prev; 2019 Sep; 28(5):413-419. PubMed ID: 30444754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening colonoscopy and fecal occult blood testing practice patterns: a population-based survey of gastroenterologists.
    Rossi F; Sosa JA; Aslanian HR
    J Clin Gastroenterol; 2008; 42(10):1089-94. PubMed ID: 18936643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
    Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
    Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national survey of primary care physicians' colorectal cancer screening recommendations and practices.
    Klabunde CN; Frame PS; Meadow A; Jones E; Nadel M; Vernon SW
    Prev Med; 2003 Mar; 36(3):352-62. PubMed ID: 12634026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family Physicians' Knowledge, Attitudes, and Practices Toward Colorectal Cancer Screening.
    Şahin MK; Aker S
    J Cancer Educ; 2017 Dec; 32(4):908-913. PubMed ID: 27193411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicians' view on sigmoidoscopy as an additionally offered method for colorectal cancer screening.
    Cespedes I; Seidler U; Walter U; Dreier M
    Z Gastroenterol; 2019 Sep; 57(9):1059-1066. PubMed ID: 31525798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal Cancer Screening in Ghana: Physicians' Practices and Perceived Barriers.
    Lussiez A; Dualeh SHA; Dally CK; Opoku BK; Raghavendran K; Aitpillah F; Boateng E; Darkwah D; Gyasi-Sarpong KC; Kolars JC; Kwakye G
    World J Surg; 2021 Feb; 45(2):390-403. PubMed ID: 33145608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening in primary care: translating research into practice.
    Ornstein S; Nemeth LS; Jenkins RG; Nietert PJ
    Med Care; 2010 Oct; 48(10):900-6. PubMed ID: 20808257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of self-reported history of colorectal cancer screening.
    Khoja S; McGregor SE; Hilsden RJ
    Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening and surveillance: a survey among Thai general surgeons.
    Lohsiriwat V; Lohsiriwat D; Thavichaigarn P;
    Asian Pac J Cancer Prev; 2009; 10(3):467-70. PubMed ID: 19640193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.